09/28/2020
In this video, William Busse, MD, discusses the results of his study on the effectiveness of treatment with benralizumab in adolescent patients with uncontrolled asthma.
Additional Resource:
- Busse W, Bleecker E, FitzGerald JM, et al. Three-year safety and efficacy of benralizumab for adolescent patients with severe, uncontrolled asthma: results of the BORA extension study. JACI. 2020;145(2)Supp AB174. DOI:https://doi.org/10.1016/j.jaci.2019.12.363
William Busse, MD, is a professor of allergy and immunology in the Clinical Science Center at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin.
